CASSS Sharing Science Solutions Bioassays 2025

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Immunologists, Pharmacologists, Clinical Pathologists, and Oncologists

+ Sample video: contact me for sample video

+ Information:

Bioassays: Scientific Approaches & Regulatory Strategies (April 7–9, 2025) is a leading bioassay symposium providing a unique opportunity to interact with key industry thought leaders. The conference focuses on current perspectives, strategies, and technologies used for bioassays, maintaining a tradition of high-quality case studies and scientific discussion that emphasizes both the technical and regulatory details of method development and standardization.

Learning Objectives

• Evaluate current perspectives, regulatory strategies, and technologies used in bioassay development.

• Analyze technical and regulatory details through high-quality case studies and scientific discussions.

• Formulate strategies for the development and standardization of methods used for bioassays.

• Implement specific bioassay strategies for multi-specific antibodies and antibody-drug conjugates.

• Assess emerging innovations and the development of new target cell lines to evaluate cytotoxicity.

Target Audience

Attendees interacting with key industry thought leaders to discuss topics such as current perspectives, strategies, and technologies used for bioassays.

Best for Immunologists, Pharmacologists, Clinical Pathologists, and Oncologists.

Topics

• CASSS Welcome and Introductory Comments

• Keynote Presentation: The Special World of Bioassay Key Learnings Special Situations and Keys to Success

• Session I: Bioassays Foundations Nuts and Bolts of Bioassays

• Session I: Panel Discussion

• Session II: Bioassay Strategies for Multi-Specific Antibodies

• Session II: Panel Discussion

• Session III: Antibody Drug Conjugates

• Session III: Panel Discussion

• Session IV: Emerging Technologies Innovations in Bioassays

• Session IV: Panel Discussion

• Session V: Panel Discussion

• Development of a New Class of Target Cell Lines to Evaluate Fc-Mediated Cytotoxicity Presented by Svar Life Science

• Lunch and Learn Vendor Showcase

• Closing Remarks and Invitation to Bioassays 2026